ART Clinical Trial - A Sibling Oocyte Study- Comparison of ZyMotTM

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate whether the percentage of good quality embryo formation following Intracytoplasmic Sperm Injection (ICSI) is improved with the use of ZyMot method of microfluidic sperm separation compared to density gradient.

Clinical Trial Description

During an in vitro fertilization (IVF) cycle, eggs are removed from a woman's ovaries via a minor surgical procedure and are inseminated with sperm in order to create embryos. The insemination process can be via standard IVF or intracytoplasmic sperm injection (ICSI.) Standard IVF is the process of placing thousands of sperm in a culture dish with one or more eggs and allowing them to interact on their own. ICSI is the process by which one sperm is directly injected into each egg. Prior to using the sperm for insemination, a semen sample is processed and washed in order to obtain the healthiest sperm. A standard sperm preparation procedure is density gradient, in which the sperm is spun via centrifugation and separated from the seminal fluid. An alternate method is via microfluidics, by which the sperm swim up a microfluidic gradient created by a microporous filter between two chambers of a device. Sperm that are capable of navigating through this filter and reaching the end chamber are presumed to be the healthiest sperm. There is some data revealing that ZyMot microfluidics yields healthier sperm compared to the density gradient technique. The aim of the study is to evaluate whether good quality embryo formation is any different following insemination with sperm separated by microfluidics compared to density gradient. On the day of oocyte retrieval, the sperm sample will be split between the two different processing methods: density gradient and ZyMot microfluidics. In the event that there are 6 or more mature oocytes and ICSI will be used for insemination, half of the oocytes will be inseminated with sperm processed by density gradient and half with sperm processed by ZyMot microfluidics. The percentage of good quality embryo formation will be compared between the two groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04818593
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Completed
Phase	N/A
Start date	June 18, 2021
Completion date	November 29, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06044792` - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed	`NCT04039217` - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM	Phase 4
Active, not recruiting	`NCT04588883` - Strengthening Families Living With HIV in Kenya	N/A
Not yet recruiting	`NCT03120884` - Intracytoplasmic Sperm Injection in Non-male Factor Infertility in Advanced Maternal Age	N/A
Recruiting	`NCT03421314` - Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.	N/A
Completed	`NCT04546412` - Importance of the Microtubule Cytoskeleton in Oocyte Competence
Completed	`NCT03343938` - Evaluation of a Closed Assisted Reproductive Technology (ART) Station Versus an Open Flow Cabinet	N/A
Completed	`NCT03808194` - Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional Incentives	N/A
Active, not recruiting	`NCT04910711` - Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV	Phase 4
Completed	`NCT04714255` - Efficacy of Art Intervention on Decreasing Pain and Anxiety During Intravenous Cannulation	N/A
Recruiting	`NCT03804294` - Effect of Vitamin D on Outcome of Assisted Reproductive Technology(ART);
Recruiting	`NCT05090150` - The SMART ART Study	N/A
Recruiting	`NCT05075174` - Effect of Progesterone Levels on 15th Day After Embryo Transfer in Early Miscarriage < 7 WG or Evolving Pregancy Rates
Recruiting	`NCT05358678` - Cesarean Section Scar Niche: The Impact on ART Outcome
Completed	`NCT02929992` - Delivery Optimization for Antiretroviral Therapy (The DO ART Study)	N/A
Recruiting	`NCT05528536` - Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain	N/A
Completed	`NCT04396210` - Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic
Completed	`NCT05053178` - The Effect of Mindfulness-Based Mandala Activity on Anxiety and Spiritual Well-Being Levels of Senior Nursing Students	N/A
Recruiting	`NCT06374758` - Accelerated ART Initiation for PWHIV Who Are Out of Care	Phase 4
Not yet recruiting	`NCT06334003` - Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Sibling Oocyte Study- Comparison of ZyMotTM Microfluidics Device to Density Gradient for Sperm Selection During ICSI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms